BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 26140431)

  • 1. Fanconi anemia gene variants in therapy-related myeloid neoplasms.
    Voso MT; Fabiani E; Zang Z; Fianchi L; Falconi G; Padella A; Martini M; Li Zhang S; Santangelo R; Larocca LM; Criscuolo M; La Brocca A; Cutcutache I; Rozen S; Simonetti G; Manfrini M; Martinelli G; Hohaus S; Leone G; Tan P; Tenen DG
    Blood Cancer J; 2015 Jul; 5(7):e323. PubMed ID: 26140431
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer risks in Fanconi anemia: findings from the German Fanconi Anemia Registry.
    Rosenberg PS; Alter BP; Ebell W
    Haematologica; 2008 Apr; 93(4):511-7. PubMed ID: 18322251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fanconi anemia is a highly penetrant cancer susceptibility syndrome.
    Dokal I
    Haematologica; 2008 Apr; 93(4):486-8. PubMed ID: 18379006
    [No Abstract]   [Full Text] [Related]  

  • 4. Rare variants in Fanconi anemia genes are enriched in acute myeloid leukemia.
    Maung KZY; Leo PJ; Bassal M; Casolari DA; Gray JX; Bray SC; Pederson S; Singhal D; Samaraweera SE; Nguyen T; Cildir G; Marshall M; Ewing A; Duncan EL; Brown MA; Saal R; Tergaonkar V; To LB; Marlton P; Gill D; Lewis I; Deans AJ; Brown AL; D'Andrea RJ; Gonda TJ
    Blood Cancer J; 2018 Jun; 8(6):50. PubMed ID: 29891941
    [No Abstract]   [Full Text] [Related]  

  • 5. Aberrant Fanconi anaemia protein profiles in acute myeloid leukaemia cells.
    Xie Y; de Winter JP; Waisfisz Q; Nieuwint AW; Scheper RJ; Arwert F; Hoatlin ME; Ossenkoppele GJ; Schuurhuis GJ; Joenje H
    Br J Haematol; 2000 Dec; 111(4):1057-64. PubMed ID: 11167740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.
    Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N;
    Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fanconi anemia and breast cancer susceptibility.
    Patel KJ
    Nat Genet; 2007 Feb; 39(2):142-3. PubMed ID: 17262024
    [No Abstract]   [Full Text] [Related]  

  • 8. Fanconi anemia is associated with a defect in the BRCA2 partner PALB2.
    Xia B; Dorsman JC; Ameziane N; de Vries Y; Rooimans MA; Sheng Q; Pals G; Errami A; Gluckman E; Llera J; Wang W; Livingston DM; Joenje H; de Winter JP
    Nat Genet; 2007 Feb; 39(2):159-61. PubMed ID: 17200672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Finnish Fanconi anemia mutations and hereditary predisposition to breast and prostate cancer.
    Mantere T; Haanpää M; Hanenberg H; Schleutker J; Kallioniemi A; Kähkönen M; Parto K; Avela K; Aittomäki K; von Koskull H; Hartikainen JM; Kosma VM; Laasanen SL; Mannermaa A; Pylkäs K; Winqvist R
    Clin Genet; 2015 Jul; 88(1):68-73. PubMed ID: 24989076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fanconi anemia pathway--the way of DNA interstrand cross-link repair.
    Yao CJ; Du W; Zhang Q; Zhang F; Zeng F; Chen FP
    Pharmazie; 2013 Jan; 68(1):5-11. PubMed ID: 23444773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent progress in understanding molecular pathogenesis of Fanconi anemia].
    Yamashita T; Oda T; Sekimoto T
    Rinsho Ketsueki; 2009 Jul; 50(7):538-46. PubMed ID: 19638721
    [No Abstract]   [Full Text] [Related]  

  • 12. Current clinical management of Fanconi anemia.
    Smith AR; Wagner JE
    Expert Rev Hematol; 2012 Oct; 5(5):513-22. PubMed ID: 23146055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical phenotype of children with Fanconi anemia caused by biallelic FANCD1/BRCA2 mutations.
    Myers K; Davies SM; Harris RE; Spunt SL; Smolarek T; Zimmerman S; McMasters R; Wagner L; Mueller R; Auerbach AD; Mehta PA
    Pediatr Blood Cancer; 2012 Mar; 58(3):462-5. PubMed ID: 21548014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy-related acute myeloid leukaemia with t(8;16)(p11;p13);MOZ-CBP and polymorphisms in detoxifying and DNA repair genes.
    Boyd EM; Bench AJ; Vaghela KJ; Campbell GN; Chowdhury FB; Gudgin EJ; Scott MA; Erber WN
    Leukemia; 2009 Jun; 23(6):1164-7. PubMed ID: 19158836
    [No Abstract]   [Full Text] [Related]  

  • 15. Fanconi anemia.
    Auerbach AD
    Dermatol Clin; 1995 Jan; 13(1):41-9. PubMed ID: 7712649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonality studies and N-ras and p53 mutation analysis of hematopoietic cells in Fanconi anemia.
    Venkatraj VS; Gaidano G; Auerbach AD
    Leukemia; 1994 Aug; 8(8):1354-8. PubMed ID: 8057673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the Fanconi anemia network in the response to DNA replication stress.
    Gari K; Constantinou A
    Crit Rev Biochem Mol Biol; 2009; 44(5):292-325. PubMed ID: 19728769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-2-induced graft-versus-leukemia for the treatment of AML in a BRCA2 Fanconi anemia patient.
    Yeo CJ; Gilman AL
    J Pediatr Hematol Oncol; 2014 Mar; 36(2):e78-80. PubMed ID: 23619121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute myeloid leukemia with complex hypodiploidy and loss of heterozygosity of 17p in a boy with Fanconi anemia.
    Woo HI; Kim HJ; Lee SH; Yoo KH; Koo HH; Kim SH
    Ann Clin Lab Sci; 2011; 41(1):66-70. PubMed ID: 21325258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fanconi anemia presenting as acute myeloid leukemia: a case report.
    Bhatia A; Dash S; Varma N; Marwaha RK
    Indian J Pathol Microbiol; 2007 Apr; 50(2):441-3. PubMed ID: 17883104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.